PRIMARY ALDOSTERONISM
Clinical trials for PRIMARY ALDOSTERONISM explained in plain language.
Never miss a new study
Get alerted when new PRIMARY ALDOSTERONISM trials appear
Sign up with your email to follow new studies for PRIMARY ALDOSTERONISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for stubborn Hormone-Linked high blood pressure
Disease control CompletedThis study tested an investigational drug called CIN-107 for adults with primary aldosteronism, a condition where the adrenal glands produce too much of a hormone, causing hard-to-control high blood pressure. The main goals were to see if the drug was safe and if it could effecti…
Matched conditions: PRIMARY ALDOSTERONISM
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for controlling stubborn hormonal high blood pressure
Disease control CompletedThis study tested a new drug called finerenone for people with primary aldosteronism, a common cause of hard-to-treat high blood pressure. The research involved 55 patients to see if finerenone safely lowers blood pressure and protects the heart and kidneys better than current op…
Matched conditions: PRIMARY ALDOSTERONISM
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Simple blood test could unlock cure for millions with stubborn high blood pressure
Diagnosis CompletedThis study tested whether using a simple blood test more widely could help find more people with a specific, treatable cause of high blood pressure called Primary Aldosteronism (PA). Researchers checked 53 adults with high blood pressure to see how many cases of PA were being mis…
Matched conditions: PRIMARY ALDOSTERONISM
Sponsor: The Cleveland Clinic • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC